Antagonism of the antinociceptive effect of nitrous oxide by inhibition of enzyme activity or expression of neuronal nitric oxide synthase in the mouse brain and spinal cord

European Journal of Pharmacology

Volumn 626, Issue 2-3, 2010, Pages 234-238

  Cope, Jessica Lack ^a   Chung, Eunhee ^a   Ohgami, Yusuke ^a   Quock, Raymond M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Antinociception; Antisense; Nitric oxide; Nitrous oxide; NOS inhibitor; Transgenic mice

Indexed keywords

ACETIC ACID; ANTISENSE OLIGODEOXYNUCLEOTIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROUS OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HOMOZYGOSITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SWISS WEBSTER MOUSE; WILD TYPE;

ANALGESICS; ANIMALS; BASE SEQUENCE; CEREBRAL VENTRICLES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKOUT TECHNIQUES; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; NITRIC OXIDE SYNTHASE TYPE I; NITROUS OXIDE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; SPINAL CORD;

EID: 70649100014     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.059     Document Type: Article

References (45)

1. Abacioǧlu N., Ozmen R., Cakici I., Tunçtan B., and Kanzik I. Role of l-arginine/nitric oxide pathway in the antinociceptive activities of morphine and mepyramine in mice. Arzneimittelforschung 51 (2001) 977-983
2. Aley K.O., McCarter G., and Levine J.D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 18 (1998) 7008-7014
3. Berkowitz B.A., Finck A.D., Hynes M.D., and Ngai S.H. Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology 51 (1979) 309-312
4. Branda E.M., Ramza J.T., Cahill F.J., Tseng L.F., and Quock R.M. Role of brain dynorphin in nitrous oxide antinociception in mice. Pharmacol. Biochem. Behav. 65 (2000) 217-222
5. Cahill F.J., Ellenberger E.A., Mueller J.L., Tseng L.F., and Quock R.M. Antagonism of nitrous oxide antinociception in mice by intrathecally administered opioid peptide antisera. J. Biomed. Sci. 7 (2000) 299-303
6. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., and Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8 (2007) 766-775
7. Cardenas A., Moro M.A., Hurtado O., Leza J.C., and Lizasoain I. Dual role of nitric oxide in adult neurogenesis. Brain Res. Rev. 50 (2005) 1-6
8. Chen S.R., and Pan H.L. Spinal nitric oxide contributes to the analgesic effect of intrathecal (D-Pen2, D-Pen5)-enkephalin in normal and diabetic rats. Anesthesiology 98 (2003) 217-222
9. Chung E., Burke B., Bieber A.J., Doss J.C., Ohgami Y., and Quock R.M. Dynorphin-mediated antinociceptive effects of l-arginine and SIN-1 (an NO donor) in mice. Brain Res. Bull. 70 (2006) 245-250
10. da Silva G.L., Matteussi A.S., dos Santos A.R.S., Calixto J.B., and Rodrigues A.L. Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. NeuroReport 11 (2000) 3699-3702
11. Ferraro G., and Sardo P. Nitric oxide and brain hyperexcitability. In Vivo 18 (2004) 357-366
12. Ferreira S.H., Lorenzetti B.B., and Faccioli L.H. Blockade of hyperalgesia and neurogenic oedema by topical application of nitroglycerin. Eur. J. Pharmacol. 217 (1992) 207-209
13. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12 (1957) 12-15
14. Handy R.L., and Moore P.K. Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology 37 (1998) 37-43
15. Hara S., Kuhns E.R., Ellenberger E.A., Mueller J.L., Shibuya T., Endo T., and Quock R.M. Involvement of nitric oxide in intracerebroventricular -endorphin-induced neuronal release of methionine-enkephalin. Brain Res. 675 (1995) 190-194
16. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., and Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75 (1993) 1273-1286
17. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new concept. Eur. J. Pharmacol. 167 (1980) 313-316
18. Iwamoto E.T., and Marion L. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an l-arginine/nitric oxide/cyclic GMP cascade in rats. J. Pharmacol. Exp. Ther. 271 (1994) 601-608
19. Iwamoto E.T., and Marion L. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. J. Pharmacol. Exp. Ther. 269 (1994) 699-708
20. Jain N.K., Patil C.S., Singh A., and Kulkarni S.K. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res. 909 (2001) 170-178
21. Ji X.Q., and Zhu X.Z. Possible involvement of nitric oxide in arginine-induced analgesia. Acta Pharmacol. Sin. 14 (1993) 289-291
22. Kolesnikov Y.A., Pan Y.X., Babey A.M., Jain S., Wilson R., and Pasternak G.W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 8220-8225
23. Lauretti G.R., de Oliveira R., Reis M.P., Mattos A.L., and Pereita N.L. Transdermal nitroglycerine enhances spinal sufentanil postoperative analgesia following orthopedic surgery. Anesthesiology 90 (1999) 734-739
24. Lauretti G.R., Perez M.V., Reis M.P., and Pereira N.L. Double-blind evaluation of transdermal nitroglycerine as adjuvant to oral morphine for cancer pain management. J. Clin. Anesth. 14 (2002) 83-86
25. Li S., Dai Y., and Quock R.M. Antisense knockdown of neuronal nitric oxide synthase antagonizes nitrous oxide-induced behavior. Brain Res. 968 (2003) 167-170
26. Lui P.W., and Lee C.H. Preemptive effects of intrathecal cyclooxygenase inhibitor or nitric oxide synthase inhibitor on thermal hypersensitivity following peripheral nerve injury. Life Sci. 75 (2004) 2527-2538
27. Machelska H., Labuz D., Przewłocki R., and Przewłocka B. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J. Pharmacol. Exp. Ther. 282 (1997) 977-984
28. McDonald C.E., Gagnon M.J., Ellenberger E.A., Hodges B.L., Ream J.K., Tousman S.A., and Quock R.M. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats. J. Pharmacol. Exp. Ther. 269 (1994) 601-608
29. Meller S.T., and Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52 (1993) 127-136
30. G-nitro arginine (L-NOARG), a novel, l-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br. J. Pharmacol. 99 (1990) 408-412
31. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102 (1991) 198-202
32. Pataki I., and Telegdy G. Further evidence that nitric oxide modifies acute and chronic morphine actions in mice. Eur. J. Pharmacol. 357 (1998) 157-162
33. Patil C.S., Jain N.K., Singh V.P., and Kulkarni S.K. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception. Indian J. Exp. Biol. 42 (2004) 361-367
34. Prado W.A., Schiavon V.F., and Cunha F.Q. Dual effect of local application of nitric oxide donors in a model of incision pain in rats. Eur. J. Pharmacol. 441 (2002) 57-65
35. Przesmycki K., Dzieciuch J.A., Czuczwar S.J., and Kleinrok Z. Nitric oxide modulates spinal antinociceptive effect of clonidine but not that of baclofen in the formalin test in rats. Eur. Neuropsychopharmacol. 9 (1999) 115-121
36. Quock R.M., Best J.A., Chen D.C., Vaughn L.K., Portoghese P.S., and Takemori A.E. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal κ-opioid receptors. Eur. J. Pharmacol. 175 (1990) 97-100 Corrigendum 187, 564
37. Quock R.M., Kouchich F.J., and Tseng L.F. Does nitrous oxide induce release of brain opioid peptides?. Pharmacology 30 (1985) 95-99
38. Rees D.D., Palmer R.M., Schulz R., Hodson H.F., and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101 (1990) 746-752
39. Schmidtko A., Tegeder I., and Geisslinger G. No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci. 32 (2009) 339-346
40. Siegmund E., Cadmus R., and Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc. Soc. Exp. Biol. Med. 95 (1957) 729-731 1957
41. Sousa A.M., and Prado W.A. The dual effect of a nitric oxide donor in nociception. Brain Res. 897 (2001) 9-19
42. Spiacci Jr. A., Kanamaru F., Guimarães F.S., and Oliveira R.M. Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacol. Biochem. Behav. 88 (2008) 247-255
43. Tseng L.F., King R.C., and Fujimoto J.M. Release of immunoreactive Met-enkephalin by intraventricular β-endorphin in anesthetized rats. Regul. Pept. 14 (1986) 181-192
44. Tyers M.B. A classification of opiate receptors that mediate antinociception in animals. Br. J. Pharmacol. 69 (1980) 503-512
45. Xu J.Y., Pieper G.M., and Tseng L.F. Activation of a NO-cyclic GMP system by NO donors potentiates beta-endorphin-induced antinociception in the mouse. Pain 63 (1995) 377-383